We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$7.1B
AUM Growth
+$407M
Cap. Flow
-$92.2M
Cap. Flow %
-1.3%
Top 10 Hldgs %
23.68%
Holding
2,973
New
384
Increased
1,273
Reduced
905
Closed
264

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$33.8M
2
HD icon
Home Depot
HD
+$6.66M
3
CAT icon
Caterpillar
CAT
+$5.17M
4
DE icon
Deere & Co
DE
+$4.75M
5
AXP icon
American Express
AXP
+$2.92M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$96.8M
2
MDT icon
Medtronic
MDT
+$19.7M
3
LIN icon
Linde
LIN
+$17.9M
4
UNH icon
UnitedHealth
UNH
+$16M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$15.3M

Sector Composition

Rank Sector Weight
1 Technology 22.98%
2 Consumer Discretionary 12.04%
3 Financials 12.03%
4 Healthcare 11.82%
5 Industrials 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRIL
1776
DELISTED
Trillium Therapeutics Inc.
TRIL
$286K ﹤0.01%
+29,523
New +$278K
DNOW icon
1777
DNOW Inc
DNOW
$3.04B
$285K ﹤0.01%
30,016
+2,694
+10% +$27.8K
ADPT icon
1778
Adaptive Biotechnologies
ADPT
$3.89B
$284K ﹤0.01%
6,959
+1,419
+26% +$55.2K
NTST
1779
NETSTREIT Corp
NTST
$2.08B
$284K ﹤0.01%
12,324
+4,506
+58% +$98.4K
IMGN
1780
DELISTED
Immunogen Inc
IMGN
$284K ﹤0.01%
43,098
-5,795
-12% -$40.4K
KRON
1781
DELISTED
Kronos Bio
KRON
$284K ﹤0.01%
11,851
+7,552
+176% +$191K
OCUL icon
1782
Ocular Therapeutix
OCUL
$2.25B
$284K ﹤0.01%
20,004
+2,027
+11% +$30.8K
CAL icon
1783
Caleres
CAL
$455M
$282K ﹤0.01%
10,349
+2,963
+40% +$74.3K
OMER icon
1784
Omeros
OMER
$1.26B
$282K ﹤0.01%
19,002
+764
+4% +$12.8K
DMTK
1785
DELISTED
DermTech, Inc. Common Stock
DMTK
$281K ﹤0.01%
6,771
+3,647
+117% +$150K
PFBC icon
1786
Preferred Bank
PFBC
$1.26B
$281K ﹤0.01%
4,440
-11
-0.2% -$732
HFWA icon
1787
Heritage Financial
HFWA
$1.22B
$281K ﹤0.01%
11,226
+686
+7% +$19.1K
RXT icon
1788
Rackspace Technology
RXT
$1.1B
$280K ﹤0.01%
14,290
+4,329
+43% +$95.9K
NTUS
1789
DELISTED
Natus Medical Inc
NTUS
$280K ﹤0.01%
10,778
+622
+6% +$16.9K
LDL
1790
DELISTED
Lydall, Inc.
LDL
$280K ﹤0.01%
4,626
-695
-13% -$26.7K
CNR
1791
DELISTED
Cornerstone Building Brands, Inc.
CNR
$279K ﹤0.01%
15,374
+3,304
+27% +$53.2K
NHC icon
1792
National Healthcare
NHC
$3.47B
$279K ﹤0.01%
3,996
+235
+6% +$17.1K
KIDS icon
1793
OrthoPediatrics
KIDS
$653M
$279K ﹤0.01%
4,418
– –
DFIN icon
1794
Donnelley Financial Solutions
DFIN
$1.17B
$279K ﹤0.01%
8,457
-1,611
-16% -$48K
FRG
1795
DELISTED
Franchise Group, Inc.
FRG
$279K ﹤0.01%
7,907
+1,661
+27% +$61.1K
PAYA
1796
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
$279K ﹤0.01%
+25,285
New +$269K
FOUR icon
1797
Shift4
FOUR
$3.47B
$279K ﹤0.01%
+2,973
New +$281K
PI icon
1798
Impinj
PI
$5.49B
$279K ﹤0.01%
5,399
+230
+4% +$11.8K
NOG icon
1799
Northern Oil and Gas
NOG
$2.57B
$278K ﹤0.01%
+13,397
New +$218K
QNCX icon
1800
Quince Therapeutics
QNCX
$31.8M
$278K ﹤0.01%
26
+1
+4% +$8.38K
70 71
72
73 74

Similar funds

RM
Rudius Management New York $358M AUM 12.23% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $359M AUM 146.87% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
KLWA
Kelly Lawrence W & Associates Pasadens, California $360M AUM 16.9% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 Portfolio in Review

As of Q2 2021, Metropolitan Life Insurance Company (MetLife) held 2,973 positions worth $7.1B, up 6.1% from $6.69B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 filing shows 384 new, 1,273 increased, 905 reduced and 264 closed positions. Its largest new stake was Palantir: 112,538 shares worth $2.97M. The largest sale was Alphabet (Google) Class C, an estimated $96.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2021 buy was Palantir: 112,538 shares worth $2.97M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $33.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $16M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alphabet (Google) Class C in Q2 2021, selling an estimated $96.8M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $7.1B portfolio in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 384 new positions and closed 264 in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.1% quarter-over-quarter to $7.1B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2021, filed 16 Aug 2021.